updated 2/23/2011 7:16:18 AM ET 2011-02-23T12:16:18

DALLAS, Feb. 23, 2011 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces an investment report featuring Radient Pharmaceuticals Corp. (AMEX:RPC). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

The full report is available at: www.microstockprofit.com/lp/RPC

Radient Pharmaceuticals Corp. (RPC) is a Tustin, Calif.-based company focused on the discovery, development and commercialization of diagnostic tests that help physicians answer clinical questions related to early disease-state detection, treatment strategy and the monitoring of disease progression or recurrence. The Company offers its FDA-cleared In Vitro Diagnostic Onko-SureTest Kits for colon-rectal cancer recurrence monitoring.

RCP was incorporated in 1988. It has two subsidiaries: AMDL Diagnostics Inc., which is also located in Tustin, California; and Jade Pharmaceuticals Inc., which is located in Shenzhen, China.

For only $19 a month, you can sign up for our real-time stock alert service.  Click here to join now:   http://www.pennystocklive.com/premium-membership/

In the report, the analyst notes:

"Shares of RPC added $0.06, or 8.96%, to close at $0.73 Monday. Approximately 11.08 million shares have traded hands Tuesday compared with the stock's average daily volume of about 3.64 million shares. RPC has so far reached a 52-week high of $2.59, its 52-week low being $0.21. It is currently trading below its 50-day moving average of $0.82 and above its 200-day moving average of $0.64.

"For the three-month period ending September 30, 2010, RPC reported revenues of approximately $34,446 compared with revenues of approximately $2.7 million in the third quarter of fiscal year 2009."

To read the entire report visit: www.microstockprofit.com/lp/RPC

See what investors are saying about RPC at http://www.stockhideout.com

Get breaking news on RPC at http://thestockmarketwatch.com/

MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on MicroStockProfit please visit: http://www.microstockprofit.com

MicroStockProfit.com Disclosure

MicroStockProfit.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors, LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, MicroStockProfit.com, for complete risks and disclosures.

CONTACT: Brian Johnson

© Copyright 2012, GlobeNewswire, Inc. All Rights Reserved


Discussion comments


Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 3.79%
$30K home equity loan FICO 4.99%
$75K home equity loan FICO 4.69%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.83%
Cash Back Cards 17.80%
Rewards Cards 17.18%
Source: Bankrate.com